Thomas Weisel Downgrades Luminex (LMNX) to Market Weight
More News related to LMNX
- Luminex Corporation and Mingyuan Medicare Development Company Sign Distribution Agreement
- Luminex Corporation Announces First Commercial Shipment of FLEXMAP 3D Systems
- Unusual 11 Mid-Day Movers 11/07: LFG, FSYS, AN, KNOT Higher; GNW, DPTR, EGOV, SRZ Lower
- Luminex Corp (LMNX) Tops Q3 View By 7c
- Luminex Corporation Reports Third Quarter 2008 Results
More News related to Downgrades
- Friedman Billings Starts Aircastle (AYR) at Underperform
- Friedman Billings Starts Netflix (NFLX) at Market Perform
- Credit Suisse Starts 3PAR (PAR) at Neutral
- Credit Suisse Starts Netezza (NZ) at Neutral
- FBR Starts Amazon.com (AMZN) at Market Perform
Thomas Weisel downgrades Luminex (Nasdaq: LMNX) from Overweight to Market Weight with a $26 price target.
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for applications in the life sciences industry.
Related Categories
DowngradesStocks Mentioned
-1.47Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
